All articles by Scarlett Evans

  1. Emulate and AstraZeneca announce Organs-on-Chips partnership

    AstraZeneca has announced a collaboration with Emulate to develop and embed the start-up’s Organs-on-Chips technology within its Innovative Medicines and…
    Read More…

    21 May
  2. CBD shown to reduce number of seizures in epilepsy patients

    A recent study by the NYU School of Medicine has found cannabidiol (CBD)-based drug Epidiolex significantly reduces the frequency of…
    Read More…

    17 May
  3. FDA approves first non-opioid treatment for opioid withdrawal

    The US Food and Drug Administration (FDA) has announced its approval of Lucemyra (lofexidine hydrochloride), the first non-opioid medication intended…
    Read More…

    17 May
  4. Cell recycling process could treat neurodegenerative conditions

    Researchers from Brown University in Providence, US, have discovered a new means of stimulating autophagy, the process by which cells…
    Read More…

    17 May
  5. BioLamina and Novo Nordisk announce stem cell collaboration

    BioLamina has announced a partnership with Danish pharma Novo Nordisk to develop stem cell-based therapies based on Biolaminins, human recombinant…
    Read More…

    16 May
  6. Researchers test flexible cancer research model

    Researchers at the University of Texas MD Anderson Cancer Center are investigating a new model for improving the development and…
    Read More…

    16 May
  7. Emergex receives £1m grant for universal flu vaccine

    UK-based biotech Emergex Vaccines has received almost £1 million to accelerate its universal flu vaccine through preclinical trials. The British…
    Read More…

    16 May
  8. LIDDS verifies NanoZolid for controlled release of cancer drugs

    Local Intelligent Drug Delivery System (LIDDS) has verified its NanoZolid technology as a subcutaneous depot for systemic delivery of pharmaceutically…
    Read More…

    16 May
  9. New molecule could provide treatment for the common cold

    Researchers at Imperial College London have developed a molecule that prevents the common cold virus from hijacking human cells, offering…
    Read More…

    15 May
  10. Polyneuron completes seed financing for autoimmune treatments

    Polyneuron pharmaceuticals has completed its CHF3.1 million seed financing round, the proceeds of which will be used to propel its…
    Read More…

    14 May

Go Top